| Title |
It is unprecedented: trial management during the COVID-19 pandemic and beyond
|
|---|---|
| Published in |
Trials, September 2020
|
| DOI | 10.1186/s13063-020-04711-6 |
| Pubmed ID | |
| Authors |
Eleanor J. Mitchell, Khaled Ahmed, Suzanne Breeman, Seonaidh Cotton, Lynda Constable, Gillian Ferry, Kirsteen Goodman, Helen Hickey, Garry Meakin, Katy Mironov, Niamh Quann, Natalie Wakefield, Alison McDonald |
X Demographics
The data shown below were collected from the profiles of 44 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 19 | 43% |
| Canada | 3 | 7% |
| Ireland | 3 | 7% |
| Australia | 1 | 2% |
| France | 1 | 2% |
| Unknown | 17 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 73% |
| Scientists | 9 | 20% |
| Practitioners (doctors, other healthcare professionals) | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 142 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 15% |
| Student > Ph. D. Student | 17 | 12% |
| Student > Bachelor | 13 | 9% |
| Other | 12 | 8% |
| Student > Master | 11 | 8% |
| Other | 20 | 14% |
| Unknown | 48 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 23% |
| Nursing and Health Professions | 9 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Social Sciences | 7 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Other | 27 | 19% |
| Unknown | 51 | 36% |